Our study revealed that intraperitoneal (i.p.)injection of DHC in apolipoprotein E-deficient (ApoE−/−) mice not only inhibited atherosclerosis development but also improved aortic compliance and increased plaque stability. The gene discussed is APOE; the disease is atherosclerosis.